Wealth Enhancement Advisory Services
IRWD icon

Wealth Enhancement Advisory Services’s Ironwood Pharmaceuticals IRWD Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$777K Sell
214,094
-5,351
-2% -$22.3K ﹤0.01% 2382
2026
Q2 		$913K Sell
219,445
-7,243
-3% -$27.9K ﹤0.01% 2139
2026
Q1 		$741K Buy
226,688
+71,165
+46% +$292K ﹤0.01% 2025
2025
Q4 		$665K Buy
155,523
+1,135
+0.7% +$2.95K ﹤0.01% 2262
2025
Q3 		$235K Buy
154,388
+28,928
+23% +$29.9K ﹤0.01% 2989
2025
Q2 		$96.1K Buy
125,460
+101,574
+425% +$79.7K ﹤0.01% 3144
2025
Q1 		$35.1K Buy
23,886
+10,651
+80% +$25.4K ﹤0.01% 2874
2024
Q4 		$58.6K Buy
+13,235
New +$53.7K ﹤0.01% 2854
2024
Q3 		– Sell
-13,608
Closed -$88.7K – 2863
2024
Q2 		$88.7K Buy
+13,608
New +$96.3K ﹤0.01% 2417

Other funds holding IRWD

CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
SmartHarvest Portfolios
SmartHarvest Portfolios Poulsbo, Washington $258M AUM 39.79% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Range Financial Group
Range Financial Group Tigard, Oregon $361M AUM 58.71% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Kathmere Capital Management
Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.3% 1-Year Est. Return
Krilogy Financial
Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return
Magnus Financial Group
Magnus Financial Group New York $1.5B AUM 16.47% 1-Year Est. Return

Wealth Enhancement Advisory Services's IRWD Position: Q3 2026 in Review

Wealth Enhancement Advisory Services reduced its Ironwood Pharmaceuticals (IRWD) stake by 2.4% in Q3 2026, selling an estimated $22.3K and leaving 214,094 shares worth $777K. The position accounts for ﹤0.01% of the portfolio, ranked #2382.

Wealth Enhancement Advisory Services first reported a position in IRWD in Q2 2024 and has held it in 9 quarters since. The position peaked at $913K in Q2 2026. 36 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • Wealth Enhancement Advisory Services held 214,094 shares of Ironwood Pharmaceuticals worth $777K as of Q3 2026.
  • Wealth Enhancement Advisory Services sold 5,351 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $22.3K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #2382 holding.
  • Wealth Enhancement Advisory Services first reported a position in Ironwood Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Wealth Enhancement Advisory Services's Ironwood Pharmaceuticals position peaked at $913K in Q2 2026.
  • 36 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.